Abstract:AIM: Ursolic acid (UA) and oleanolic acid (OA) are triperpene acids having a similar chemical structure and are distributed wildly in plants all over the world. In recent years, it was found that they had marked anti-tumor effects. There is little literature currently available regarding their effects on colon carcinoma cells. The present study was designed to investigate their inhibitory effects on human colon carcinoma cell line HCT15.METHODS: HCT15 cells were cultured with different drugs. The treated cells were stained with hematoxylin-eosin and their morphologic changes observed under a light microscope. The cytotoxicity of these drugs was evaluated by tetrazolium dye assay. Cell cycle analysis was performed by flow cytometry (FCM). Data were expressed as means SEM and Analysis of variance and Student' t-test for individual comparisons.RESULTS: Twenty-four to 72 h after UA or OA 60 mumol/L treatment, the numbers of dead cells and cell fragments were increased and most cells were dead at the 72 nd hour. The cytotoxicity of UA was stronger than that of OA. Seventy-eight hours after 30 mumol/L of UA or OA treatment, a number of cells were degenerated, but cell fragments were rarely seen. The IC,, values for UA and OA were 30 and 60 mumol/L, respectively. Proliferation assay showed that proliferation of UA and OA-treated cells was slightly increased at 24 In and significantly decreased at 48 h and 60 h, whereas untreated control cells maintained an exponential growth curve. Cell cycle analysis by FCM showed HCT15 cells treated with UA 30 and OA 60 for 36 h and 72 h gradually accumulated in G(0)/G(1) phase (both drugs P < 0.05 for 72 h), with a concomitant decrease of cell populations in S phase (both drugs P < 0.01 for 72 h) and no detectable apoptotic fraction.CONCLUSION: UA and OA have significant anti-tumor activity. The effect of UA is stronger than that of OA. The possible mechanism of action is that both drugs have an inhibitory effect on tumor cell proliferation through cell-cycle arrest.

A novel synthetic oleanolic acid derivative with amino acid conjugate suppresses tumour growth by inducing cell cycle arrest.

Synthesis and antitumor activity of α,β-unsaturated carbonyl moiety- containing oleanolic acid derivatives targeting PI3K/AKT/mTOR signaling pathway

Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway

Design, synthesis, and antitumor activity of novel oleanolic acid analogues targeting EGFR

Oleanolic acid derivatives induce apoptosis in human leukemia K562 cell involved in inhibition of both Akt1 translocation and pAkt1 expression

Oleanolic acid induces metabolic adaptation in cancer cells by activating the AMP-activated protein kinase pathway.

Immunomodulatory Activity of 3 Beta,6 Beta-Dihydroxyolean-12-En-27-Oic Acid in Tumor-Bearing Mice

3Β‐hydroxyolean‐12‐en‐27‐oic Acid: A Cytotoxic, Apoptosis‐Inducing Natural Drug Against COLO‐205 Cancer Cells.

Oleanolic acid derivative Dex-OA has potent anti-tumor and anti-metastatic activity on osteosarcoma cells in vitro and in vivo

Synthesis, Anti-Proliferative and Proapoptotic Activity of Novel Oleanolic Acid Azaheterocyclic Derivatives

Antitumour activity of oleanolic acid: A systematic review and meta‐analysis

Synthesis of Oleanolic Acid-Dithiocarbamate Conjugates and Evaluation of Their Broad-Spectrum Antitumor Activities

Oleanolic acid induced autophagic cell death in hepatocellular carcinoma cells via PI3K/Akt/mTOR and ROS-dependent pathway

Oleanolic Acid Inhibits Colon Cancer Cell Stemness and Reverses Chemoresistance by Suppressing JAK2/STAT3 Signaling Pathway

Synthesis and evaluation of the cancer cell growth inhibitory activity of the ionic derivatives of oleanolic acid and ursolic acid with improved solubility

Oleanolic acid induces protective autophagy in cancer cells through the JNK and mTOR pathways.

Oleanolic acid inhibits osteosarcoma cell proliferation and invasion by suppressing the SOX9/Wnt1 signaling pathway

The Inhibitory Effect of 3Β-Hydroxy-12-oleanen-27-oic Acid on Growth and Motility of Human Hepatoma HepG2 Cells Through JNK and Akt Signaling Pathway

Effects of Ursolic Acid and Oleanolic Acid on Human Colon Carcinoma Cell Line Hct15

Synthesis and Biological Evaluation of Novel Spin Labeled 18Β-Glycyrrhetinic Acid Derivatives

Oleanolic acid inhibits cervical cancer Hela cell proliferation through modulation of the ACSL4 ferroptosis signaling pathway